AP

Avinash Prakash Pateriya

Director DIN 02200617
DIN 02200617 First appointment Jul 2008
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jul 2008
Shareholding value β€’β€’β€’β€’ Premium profile

About Avinash Prakash Pateriya

Data last updated:

Avinash Prakash Pateriya was a Director at Onyx Drug House Private Limited (from 2008) and Director at Onyx Remedies Private Limited (from 2009).

DIN 02200617
First Appointment 15 Jul 2008
Oldest Company Age 18 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Onyx Drug House Private Limited U24233UP2008PTC035675
Director15 Jul 20082008Strike Off
Onyx Remedies Private Limited U24233MP2009PTC022662
Director18 Nov 20092009Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Onyx Drug House Private Limited
Onyx Remedies Private Limited
Premium access

Shareholding and investment profile for Avinash Prakash Pateriya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Avinash Prakash Pateriya

Avinash Prakash Pateriya was first appointed on 15 Jul 2008 as Director at Onyx Drug House Private Limited. The most recent appointment on record is 18 Nov 2009 at Onyx Remedies Private Limited.

Avinash Prakash Pateriya held 2 earlier board appointments: Onyx Drug House Private Limited (Director, from 15 Jul 2008); Onyx Remedies Private Limited (Director, from 18 Nov 2009).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available